IL268661A - Preparation and methods for preventing radiation damage and increasing tissue regeneration - Google Patents
Preparation and methods for preventing radiation damage and increasing tissue regenerationInfo
- Publication number
- IL268661A IL268661A IL26866119A IL26866119A IL268661A IL 268661 A IL268661 A IL 268661A IL 26866119 A IL26866119 A IL 26866119A IL 26866119 A IL26866119 A IL 26866119A IL 268661 A IL268661 A IL 268661A
- Authority
- IL
- Israel
- Prior art keywords
- composition
- methods
- tissue regeneration
- radiation injury
- promoting tissue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762459924P | 2017-02-16 | 2017-02-16 | |
PCT/US2018/000035 WO2018151823A1 (en) | 2017-02-16 | 2018-02-16 | Composition and methods for preventing radiation injury and promoting tissue regeneration |
Publications (1)
Publication Number | Publication Date |
---|---|
IL268661A true IL268661A (en) | 2019-10-31 |
Family
ID=63170684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL26866119A IL268661A (en) | 2017-02-16 | 2019-08-12 | Preparation and methods for preventing radiation damage and increasing tissue regeneration |
Country Status (13)
Country | Link |
---|---|
US (1) | US20230147795A1 (ja) |
EP (1) | EP3582754B1 (ja) |
JP (1) | JP7145163B2 (ja) |
KR (1) | KR20190135470A (ja) |
CN (1) | CN110520108A (ja) |
AU (1) | AU2018221221B2 (ja) |
BR (1) | BR112019017087A2 (ja) |
CA (1) | CA3053096A1 (ja) |
ES (1) | ES2970509T3 (ja) |
IL (1) | IL268661A (ja) |
MX (1) | MX2019009753A (ja) |
SG (2) | SG10202107725RA (ja) |
WO (1) | WO2018151823A1 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
CA2935960C (en) | 2014-01-08 | 2023-01-10 | Bart Lipkens | Acoustophoresis device with dual acoustophoretic chamber |
US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
US10785574B2 (en) | 2017-12-14 | 2020-09-22 | Flodesign Sonics, Inc. | Acoustic transducer driver and controller |
CN112969451A (zh) * | 2018-09-12 | 2021-06-15 | 福斯特斯特林研究公司 | 使用α连接蛋白C端肽的纳米粒子制剂和方法 |
CN110358783A (zh) * | 2019-06-28 | 2019-10-22 | 深圳市容大生物技术有限公司 | 重组质粒、重组工程菌及其应用 |
KR20210104319A (ko) | 2020-02-17 | 2021-08-25 | 노태성 | 궤양 치료를 위한 조성물 |
CN114522165A (zh) * | 2022-01-21 | 2022-05-24 | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 一种氯化血根碱在制备砷致肝损伤药物或保健品方面的应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7108992B2 (en) * | 2002-11-27 | 2006-09-19 | St. Jude Children's Research Hospital | ATM kinase compositions and methods |
JPWO2006033412A1 (ja) * | 2004-09-24 | 2008-05-15 | 株式会社林原生物化学研究所 | 放射線障害軽減剤 |
CN101151043B (zh) * | 2004-12-21 | 2013-09-04 | 南卡罗来纳州医科大学研究发展基金会 | 促进伤口愈合和组织再生的组合物和方法 |
SG158153A1 (en) | 2004-12-21 | 2010-01-29 | Musc Found For Res Dev | Compositions and methods for promoting wound healing and tissue regeneration |
US9408381B2 (en) * | 2004-12-21 | 2016-08-09 | Musc Foundation For Research Development | Alpha Connexin c-Terminal (ACT) peptides for use in transplant |
AU2007314366A1 (en) * | 2006-10-30 | 2008-05-08 | Southern Research Institute | Targeting NBS1-ATM interaction to sensitize cancer cells to radiotherapy and chemotherapy |
TW201311259A (zh) * | 2011-07-15 | 2013-03-16 | Anthrogenesis Corp | 利用羊膜衍生附著性細胞治療輻射傷害 |
JP6185937B2 (ja) * | 2012-03-01 | 2017-08-23 | ファーストストリング・リサーチ・インコーポレイテッドFirststring Research,Inc. | アルファコネキシンc末端(act)ペプチド含有局所用ゲル剤 |
WO2015123383A1 (en) * | 2014-02-12 | 2015-08-20 | Rodgers Kathleen E | Methods for promoting wound healing |
-
2018
- 2018-02-16 AU AU2018221221A patent/AU2018221221B2/en active Active
- 2018-02-16 CA CA3053096A patent/CA3053096A1/en active Pending
- 2018-02-16 ES ES18754750T patent/ES2970509T3/es active Active
- 2018-02-16 US US16/486,239 patent/US20230147795A1/en active Pending
- 2018-02-16 CN CN201880025338.9A patent/CN110520108A/zh active Pending
- 2018-02-16 MX MX2019009753A patent/MX2019009753A/es unknown
- 2018-02-16 SG SG10202107725RA patent/SG10202107725RA/en unknown
- 2018-02-16 KR KR1020197024109A patent/KR20190135470A/ko not_active Application Discontinuation
- 2018-02-16 JP JP2019543906A patent/JP7145163B2/ja active Active
- 2018-02-16 WO PCT/US2018/000035 patent/WO2018151823A1/en unknown
- 2018-02-16 BR BR112019017087A patent/BR112019017087A2/pt unknown
- 2018-02-16 SG SG11201907196YA patent/SG11201907196YA/en unknown
- 2018-02-16 EP EP18754750.0A patent/EP3582754B1/en active Active
-
2019
- 2019-08-12 IL IL26866119A patent/IL268661A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN110520108A (zh) | 2019-11-29 |
US20230147795A1 (en) | 2023-05-11 |
AU2018221221B2 (en) | 2022-03-24 |
SG11201907196YA (en) | 2019-09-27 |
RU2019128841A (ru) | 2021-03-16 |
JP7145163B2 (ja) | 2022-09-30 |
AU2018221221A1 (en) | 2019-08-22 |
BR112019017087A2 (pt) | 2020-04-14 |
EP3582754B1 (en) | 2024-01-10 |
JP2020507600A (ja) | 2020-03-12 |
ES2970509T3 (es) | 2024-05-29 |
EP3582754A4 (en) | 2020-12-30 |
CA3053096A1 (en) | 2018-08-23 |
MX2019009753A (es) | 2019-12-18 |
RU2019128841A3 (ja) | 2021-06-01 |
SG10202107725RA (en) | 2021-09-29 |
KR20190135470A (ko) | 2019-12-06 |
EP3582754A1 (en) | 2019-12-25 |
WO2018151823A1 (en) | 2018-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL268661A (en) | Preparation and methods for preventing radiation damage and increasing tissue regeneration | |
ZA201701491B (en) | Methods and therapeutic combinations for treating tumors | |
SG11201700079VA (en) | Combination therapy compositions and methods for treating cancers | |
PT3518783T (pt) | Aparelho para redução de tecido | |
ZA202001880B (en) | Compositions and methods for treating brain injury | |
PL3362449T3 (pl) | Pochodne sybiriliny do zastosowania do zapobiegania i/lub leczenia zaburzeń związanych z nekroptozą komórkową | |
ZA201706919B (en) | Fixed dose combinations and formulations comprising etc1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease | |
IL249400A0 (en) | Orthopedic splints and methods for their production | |
IL269083A (en) | Methods for the prevention and treatment of heart diseases | |
IL276577A (en) | Methods for treating cardiac injury | |
HK1256541A1 (zh) | 用於處理皮膚的方法和組合物 | |
IL269743A (en) | Methods and preparations for the treatment of disease related to the retina with CCR-3 inhibitor inventions | |
IL271327A (en) | Compositions and methods for enhancing hyperthermic therapy | |
IL250114B (en) | Methods and compositions for the treatment of HIV-related diseases | |
HK1243635A1 (zh) | 治療皮膚病況的組合物和方法 | |
IL271758A (en) | Statin preparations and methods for use in the treatment of synuclein pathologies | |
HK1252796A1 (zh) | 用於周圍神經病症或脊髓損傷的治療劑和/或預防劑 | |
HK1256935A1 (zh) | 使用疫苗治療癌症或皮膚病變的方法和組合物 | |
IL258629A (en) | Methods and preparations for the treatment of traumatic brain damage | |
IL276150A (en) | Methods and compositions for treating and preventing skin barrier disruptions | |
HK1252439A1 (zh) | 用於處理人角蛋白材料的裝置 | |
IL255012A0 (en) | Preparations and methods for treating skin conditions | |
IL251825B1 (en) | Treatment of cancer and skin damage | |
IL246608A0 (en) | Preparations and methods for treating heart disease | |
GB201508931D0 (en) | Materials and methods for tissue regeneration |